I’m trying to get my friend here so that she can get information on Lantus, Levemir, and everything else MDI. She’s looking for information, but she’s looking in the wrong place. (Clearly the 670G users are a pretty confused group).
Her son was using the 670G up until recently but has switched over to Dexcom. It sounds like, as of this morning, he’s also gone back to MDI. They went onto Lantus, which was just over a year old, and found he struggled getting his BGs down below 140. She wonders whether or not that year old status could be the cause? (And I don’t think so, but I’d rather have her hear it from you all). They then switched to Levemir and saw an immediate drop to a 95ish. Her question in my group was is there a difference between Lantus and Levemir and is there a possibility one works better than the other? Also, is there a chance the Lantus had weakened over the year?
I do not know what the doses were or the timing, and I immediately thought maybe there were gaps between the doses that could’ve let him rise. Having just gone through a couple of transitions onto MDI, it has become clear to me that having good timing and an appropriate dosage is imperative to good control.
I’d love to listen to this conversation should it take off. I’m sure I’ll be back on injections soon enough.